Candriam Equities L Biotechnology Class C USD CapRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 31/03/2024 |
|
Annual Returns (GBP) | 31/03/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 31/03 | |
Price Return | 15.72 | -5.72 | 29.75 | 15.56 | -1.76 | 10.92 | 1.12 | 3.73 |
+/- Category | 5.42 | 2.25 | 9.55 | -10.41 | 7.27 | 18.76 | 2.40 | 1.42 |
+/- Category Index | 0.53 | -3.87 | 13.04 | -17.37 | -2.06 | 8.46 | -6.21 | -4.76 |
% Rank in Category | 24 | 35 | 10 | 72 | 35 | 2 | 31 | 43 |
Trailing Returns (GBP) | 25/04/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | -1.58 | -1.34 | -2.69 |
1 Week | 0.25 | -0.01 | -1.70 |
1 Month | -5.35 | 1.43 | -2.56 |
3 Months | -4.90 | -1.56 | -10.72 |
6 Months | 10.24 | -3.09 | -4.75 |
YTD | -2.86 | 2.26 | -8.77 |
1 Year | 1.22 | 0.66 | -11.74 |
3 Years Annualised | 3.78 | 9.70 | -2.32 |
5 Years Annualised | 7.90 | 2.97 | -3.63 |
10 Years Annualised | 11.26 | 2.35 | -0.47 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 31/03/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 3.73 | - | - | - |
2023 | -5.35 | -0.10 | -1.34 | 8.39 |
2022 | -4.00 | -0.05 | 13.44 | 1.91 |
2021 | -5.97 | 6.60 | 0.42 | -2.39 |
2020 | -5.34 | 25.01 | -5.87 | 3.75 |
2019 | 13.85 | 1.72 | -5.85 | 19.01 |
|
Advertisement |